UnitedHealthcare Pharmacy
Clinical Pharmacy Programs
Program Number 2025 P 2266-4
Program Prior Authorization/Medical Necessity
Medication Qlosi (pilocarpine)™ 0.4% ophthalmic solution, Vuity® (pilocarpine)
1.25% ophthalmic solution
P&T Approval Date 3/2022, 3/2023, 1/2024, 1/2025
Effective Date 4/1/2025
1. Background:
Qlosi (pilocarpine) 0.4% ophthalmic solution and Vuity (pilocarpine) 1.25% ophthalmic
solution are indicated for the treatment of presbyopia in adults. The efficacy of Qlosi was
established in clinical trials with patients aged 45 to 64 years of age with presbyopia and for
Vuity in patients aged 40 to 55 years of age with presbyopia. The standard of therapy for the
treatment of presbyopia is use of corrective lenses, such as glasses and contact lenses, or
refractive surgery.
2. Coverage Criteriaa:
A. Treatment of Presbyopia
Qlosi or Vuity is not considered medically necessary for the treatment of presbyopia based on
the definition of medically necessary health care services in the certificate of coverage.
All requests for authorization will be denied.
a State mandates may apply. Any federal regulatory requirements and the member specific benefit
plan coverage may also impact coverage criteria. Other policies and utilization management
programs may apply.
3. Additional Clinical Rules:
• Notwithstanding Coverage Criteria, UnitedHealthcare may approve initial and re-
authorization based solely on previous claim/medication history, diagnosis codes (ICD-10)
and/or claim logic. Use of automated approval and re-approval processes varies by program
and/or therapeutic class.
• Supply limits may be in place.
4. References:
1. Qlosi [package insert]. Ponte Vedra, FL: Orasis Pharmaceuticals, Ltd.; June 2024..
2. Vuity [package insert]. North Chicago, IL: AbbVie Inc.; March 2023.
2. Mian, SI. Visual impairment in adults: Refractive disorders and presbyopia. In: UpToDate,
Gardiner, MF, UpToDate, Waltham, MA, 2024.
© 2025 UnitedHealthcare Services Inc.
1
Program Prior Authorization/Medical Necessity – Qlosi, Vuity
Change Control
Date Change
3/2022 New program
3/2023 Annual review. Updated references.
1/2024 Added Qlosi. Updated references.
1/2025 Annual review. Updated references.
© 2025 UnitedHealthcare Services Inc.
2